ANESTHESIST;
ANESTHETIC RECOVERY;
CONTROLLED STUDY;
HEALTH SURVEY;
HUMAN;
IRELAND;
PEDIATRIC ANESTHESIA;
POSTOPERATIVE NAUSEA AND VOMITING;
PRIORITY JOURNAL;
QUESTIONNAIRE;
REVIEW;
UNITED KINGDOM;
ANESTHESIOLOGY;
ANESTHETICS, INTRAVENOUS;
ELECTROENCEPHALOGRAPHY;
GREAT BRITAIN;
HEALTH CARE SURVEYS;
HUMANS;
INFUSIONS, INTRAVENOUS;
IRELAND;
PEDIATRICS;
POSTOPERATIVE NAUSEA AND VOMITING;
PROPOFOL;
QUESTIONNAIRES;
SYNDROME;
TIME FACTORS;
Serious adverse effects and fatalities in children associated with the use of propofol (Diprivan) for sedation
Committee on Safety of Medicines. June 1992. Vol 34.
Committee on Safety of Medicines. Serious adverse effects and fatalities in children associated with the use of propofol (Diprivan) for sedation. Current Problems in Pharmacovigilance. June 1992. Vol 34.
Propofol (Diprivan) infusion: Sedation in children aged 16 years or younger contraindicated
Committee on Safety in Medicines, Medicines Control Agency. August 2001. Vol 27.
Committee on Safety in Medicines, Medicines Control Agency. Propofol (Diprivan) infusion: sedation in children aged 16 years or younger contraindicated. Current Problems in Pharmacovigilance. August 2001. Vol 27.
Metabolic acidosis and fatal myocardial failure after propofol infusion in children: Five case reports
Parke TJ, Stevens JE, Rice AS et al. Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five case reports. Br Med J 1992 305: 613 616.
Lacticacidosis after short-term infusion of propofol for anaesthesia in a child with osteogenesis imperfecta
Kill C, Leonhardt A, Wulf H. Lacticacidosis after short-term infusion of propofol for anaesthesia in a child with osteogenesis imperfecta. Paediatr Anaesth 2003 13: 823 826.